metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology O-40 PROGNOSTIC ROLE OF MAGNETIC RESONANCE OF THE ABDOMEN WITH INTRAVENOUS CONTR...
Información de la revista
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Acceso a texto completo
O-40 PROGNOSTIC ROLE OF MAGNETIC RESONANCE OF THE ABDOMEN WITH INTRAVENOUS CONTRAST AND CHOLANGIORESONANCE IN PRIMARY SCLEROSING CHOLANGITIS: OUR EXPERIENCE
Visitas
380
Roy López Grove1, Florencia Vespa1, Martina Aineseder1, Alejandra Villamil2, Juan Carlos Spina1
1 Department of Radiology, Buenos Aires Italian Hospital, Buenos Aires, Argentina
2 Hepatology Section, Department of Medicine, Buenos Aires Italian Hospital, Buenos Aires, Argentina
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (1)
Suplemento especial
Este artículo forma parte de:
Vol. 28. Núm S1

Abstracts of the 2022 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Primary sclerosing cholangitis (PSC) is a progressive cholestatic liver disease leading to infectious complications, biliary cirrhosis, portal hypertension and the development of cholangiocarcinoma. Imaging is essential for diagnosis. MRI risk scoring systems, called Anali without/with gadolinium, are suggested to predict disease progression. This study aimed to evaluate the usefulness of Anali scores determined by MRI of the abdomen and cholangioMR to predict the prognosis of patients with PSC.

- Analyze interobserver variability of Anali scores.

Materials and Methods

Cohort retrospective study of patients diagnosed with PSC, with baseline and follow-up MRIs (2009 to 2020). The study was approved by the institution's Ethics Committee.

MRIs were reviewed by two radiologists and Anali scores were calculated: without gadolinium= (0-2 x intrahepatic bile duct dilatation) + (2 x hepatic dysmorphism) + (1 x portal hypertension) with a possible score of 0 to 5; with gadolinium = (1 x hepatic dysmorphism) + (1 x heterogeneity of hepatic parenchymal enhancement) with a possible score of 0 to 2.

Clinical endpoints included liver transplantation, cirrhotic decompensation, or death.

Results

Twenty-nine patients were included, of whom 12 presented a clinical event on follow-up. We recorded seven liver transplants and five cirrhotic decompensations. The median time between the clinical event and MRI was 30.5 months.

Patients with a clinical event had a median Anali score without gadolinium 4 and with gadolinium 2, while in those without clinical events, the Anali score was 1 in both modalities.

The Kappa index for interobserver agreement with respect to the Anali score was 0.87 (95% CI). Kaplan-Meier survival analysis comparing event-free time according to the Anali scale was 59 months for scales 0-2 and 32 months for scales 3-5.

Conclusions

MRI Anali scores correlate with the occurrence of clinical events in PSC, with a high degree of interobserver agreement. They should be considered a useful prognostic tool in evaluating these patients.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos